Skip to content

efficacy of misoprostol on abortion therapy

Evaluation efficacy of vaginal and oral misoprostol on abortion therapy in pregnant women15-35 years old

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013090414563N1
Enrollment
70
Registered
2014-01-27
Start date
2012-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abortion therapy. Medical abortion

Interventions

Misoprostol 200 micrograms - the 400 and the 200 every 6 hours for 48 hours.
Treatment - Drugs
Misoprostol 200 micrograms - the 400 and the 200 every 6 hours for 48 hours

Sponsors

Golestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 35 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria : pregnant women undergoing therapeutic abortion; aged 15 to 35 years; satisfaction of the trial conducted in this study. The exclusion criteria : previous cesarean section; previous uterine Myomectomy;allergies and contraindications for the use of prostaglandins;vaginal bleeding before treatment; or rupture of Mambrane or vaginitis before treatment ;dissatisfaction upon entering the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Abortion therapy. Timepoint: per 6 hours to 48 hours. Method of measurement: Bougie#(6) passed through the cervix.

Secondary

MeasureTime frame
Interval between administration of the drug to induce abortion. Timepoint: Interval between Putting tablets in the vagina to induce abortion. Method of measurement: Per hour.;Adverse Drug Reactions. Timepoint: when The problem occurred. Method of measurement: researcher Find.;Indication of abortion. Timepoint: when hospitalization. Method of measurement: The researcher identified.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhgan Arman

Golestan University of Medical Sciences

m.arman@goums.ac.ir+98 17 1442 1651

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026